Overview

Xinju Xiaogao Prescription Study on Overweight

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Xinju Xiaogao prescription and 10% of it in the treatment of adiposity (stagnation of QI causing phlegm retention)clinical study
Phase:
N/A
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Collaborators:
China-Japan Friendship Hospital
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences